| Capital Markets Industry | Financials Sector | Mr. Keisuke Miyoshi CEO | OTC GREY Exchange | JP3389900006 ISIN |
| Japan Country | 159 Employees | 28 Mar 2025 Last Dividend | - Last Split | - IPO Date |
JAFCO Group Co., Ltd., previously known as JAFCO Co., Ltd., is a leading private equity and venture capital firm with a rich history in the investment sector. Established on April 5, 1973, and headquartered in Tokyo, Japan, JAFCO has expanded its presence with an additional office located in Osaka, Japan. The firm is recognized for its extensive expertise in a broad range of investment strategies, including direct investments and fund of fund investments. Its direct investment approach covers various stages and aspects of company development, from incubation and seed stage to startup, early, middle, late stages, and includes specialized areas such as buyouts, business succession, and spin-out related investments. JAFCO's investment philosophy is distinctive for its wide-ranging industry focus, targeting sectors such as life science, new drug development, regenerative medicine, medical equipment, healthcare, robotics, electronics, software, IT services, manufacturing, logistics, retail, restaurants, housing, and finance. The company has a global investment outlook, with a keen interest in opportunities within the United States of America, Japan, and Europe, reflecting its commitment to fostering innovation and growth across different geographies and sectors.
JAFCO specializes in direct investments across various stages of business development, including incubation, seed, startup, early stage, middle stage, late stage, buyouts, business succession, and spin-out related engagements. This approach facilitates the firm's involvement in the nurturing and growth of companies from their nascent stages through to maturity.
The firm undertakes fund of funds investments, enabling it to invest in a diversified portfolio of funds. This method allows JAFCO to spread risk and gain exposure to a broad range of investment opportunities across different sectors and stages without directly investing in companies.
JAFCO has a strong focus on investing in numerous fields, such as life sciences (including new drug development and regenerative medicine), medical equipment and healthcare, robotics, electronics, software, IT services, manufacturing, logistics, retail, restaurants, housing, and finance. This diversified industry approach supports the firm's strategy to be involved in high-growth and innovative sectors.
With a strategic eye on global opportunities, JAFCO invests in the United States of America, Japan, and Europe. The firm's global investment strategy underscores its objective to capture value from various market dynamics and innovation trends worldwide.